Silver Book Fact

During the past decade, growth of spending for prostate cancer has averaged 11 percent a year, outpacing rates for other common conditions such as cardiovascular and pulmonary diseases. 

Jacobs B, Zhang Y, Skolarus T, Hollenbeck B. Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse. Health Affairs. 2012; 31(4): 750-759

Reference

Title
Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Jacobs B, Zhang Y, Skolarus T, Hollenbeck B
Volume & Issue
Volume 31, Issue 4
Pages
750-759

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • Women younger than 65 are about 2 times as likely to survive ovarian cancer than a woman 65 and older.  
  • In 2007, an estimated 20,500 people (11,170 men and 9,330 women) will be diagnosed with brain and other nervous system cancers.  
  • Spending on cancer medicines represented approximately one percent of the total national health expenditures in 2011.  
  • About 20,790 deaths from lymphoma will occur in 2009 (Hodgkin lymphoma, 1,290; non-Hodgkin lymphoma, 19,500).  
  • The total cost of cancer in 2009 was $216.6 billion–$86.6 in direct medical costs and $130 billion for indirect mortality costs.